Dirk Nagorsen

Chief Medical Officer at Affini-T

Dirk Nagorsen is a seasoned medical professional with extensive experience in hematology and oncology. Currently serving as Chief Medical Officer at Affini-T Therapeutics, Dirk previously held senior roles at Amgen, including Vice President Early Development TA Head Oncology and Executive Medical Director for Early Development Hematology/Oncology. Dirk's leadership in global clinical development is complemented by a tenure as Senior Medical Director at Micromet AG. Academic achievements include appointments as Professor of Medicine at Universitätsmedizin Mannheim and Associate Professor of Medicine at Charite, along with considerable clinical practice as an Attending Physician and Group Leader. Dirk Nagorsen obtained medical degrees from Humboldt-Universität zu Berlin and Freie Universität Berlin.

Links

Previous companies

University of Heidelberg logo
Amgen logo

Org chart

Timeline

  • Chief Medical Officer

    July, 2022 - present